These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function. Eldeeb K; Leone-Kabler S; Howlett AC J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415 [TBL] [Abstract][Full Text] [Related]
11. Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors. Redmond WJ; Cawston EE; Grimsey NL; Stuart J; Edington AR; Glass M; Connor M Br J Pharmacol; 2016 Jan; 173(1):115-27. PubMed ID: 26398720 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling. Molina-Holgado F; Pinteaux E; Heenan L; Moore JD; Rothwell NJ; Gibson RM Mol Cell Neurosci; 2005 Jan; 28(1):189-94. PubMed ID: 15607953 [TBL] [Abstract][Full Text] [Related]
13. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors. Govaerts SJ; Hermans E; Lambert DM Eur J Pharm Sci; 2004 Nov; 23(3):233-43. PubMed ID: 15489124 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological and molecular characterization of a dorsal root ganglion cell line expressing cannabinoid CB(1) and CB(2) receptors. Fan Y; Hooker BA; Garrison TR; El-Kouhen OF; Idler KB; Holley-Shanks RR; Meyer MD; Yao BB Eur J Pharmacol; 2011 Jun; 659(2-3):161-8. PubMed ID: 21458448 [TBL] [Abstract][Full Text] [Related]
15. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Daigle TL; Kearn CS; Mackie K Neuropharmacology; 2008 Jan; 54(1):36-44. PubMed ID: 17681354 [TBL] [Abstract][Full Text] [Related]
16. Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland. González S; Manzanares J; Berrendero F; Wenger T; Corchero J; Bisogno T; Romero J; Fuentes JA; Di Marzo V; Ramos JA; Fernández-Ruiz J Neuroendocrinology; 1999 Aug; 70(2):137-45. PubMed ID: 10461028 [TBL] [Abstract][Full Text] [Related]
17. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Leggett JD; Aspley S; Beckett SR; D'Antona AM; Kendall DA; Kendall DA Br J Pharmacol; 2004 Jan; 141(2):253-62. PubMed ID: 14707029 [TBL] [Abstract][Full Text] [Related]
18. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell. Korzh A; Keren O; Gafni M; Bar-Josef H; Sarne Y Brain Res; 2008 Jan; 1189():23-32. PubMed ID: 18068691 [TBL] [Abstract][Full Text] [Related]
19. Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates. Gonsiorek W; Lunn CA; Fan X; Deno G; Kozlowski J; Hipkin RW Br J Pharmacol; 2007 Aug; 151(8):1262-71. PubMed ID: 17603556 [TBL] [Abstract][Full Text] [Related]
20. Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. Straiker A; Wager-Miller J; Hutchens J; Mackie K Br J Pharmacol; 2012 Apr; 165(8):2660-71. PubMed ID: 22014238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]